Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Asgn (ASGN) Receivables (2016 - 2025)

Historic Receivables for Asgn (ASGN) over the last 16 years, with Q3 2025 value amounting to $710.4 million.

  • Asgn's Receivables rose 349.65% to $710.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $710.4 million, marking a year-over-year increase of 349.65%. This contributed to the annual value of $650.8 million for FY2024, which is 1223.2% down from last year.
  • Latest data reveals that Asgn reported Receivables of $710.4 million as of Q3 2025, which was up 349.65% from $691.3 million recorded in Q2 2025.
  • In the past 5 years, Asgn's Receivables registered a high of $877.9 million during Q3 2022, and its lowest value of $624.7 million during Q2 2021.
  • For the 5-year period, Asgn's Receivables averaged around $743.0 million, with its median value being $721.4 million (2024).
  • Per our database at Business Quant, Asgn's Receivables skyrocketed by 3497.68% in 2022 and then plummeted by 1469.05% in 2024.
  • Quarter analysis of 5 years shows Asgn's Receivables stood at $708.2 million in 2021, then increased by 20.53% to $853.6 million in 2022, then dropped by 13.13% to $741.5 million in 2023, then fell by 12.23% to $650.8 million in 2024, then increased by 9.16% to $710.4 million in 2025.
  • Its Receivables stands at $710.4 million for Q3 2025, versus $691.3 million for Q2 2025 and $705.3 million for Q1 2025.